Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Conference Correspondent
News, views, and coverage of important topics and discussions from oncology conferences and events.
[widgetkit id="23" name="CC Event Nav"]
Updated Outcomes of Tucatinib versus Placebo Added to Trastuzumab and Capecitabine (HER2CLIMB) in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer with Brain Metastases
January 6, 2022
SABCS 2021 Wrap-Up
Watch Video
Results from the I-SPY 2 Trial of Tucatinib plus Paclitaxel + Pertuzumab + Trastuzumab Followed by Doxorubicin/Cyclophosphamide in High-Risk HER2-Positive Stage II/III Breast Cancer
January 6, 2022
SABCS 2021 Wrap-Up
Watch Video
A Review of the Efficacy of Tyrosine Kinase Inhibitors in the Treatment of Patients with HER2-Positive Breast Cancer with or without Brain Metastases
January 6, 2022
SABCS 2021 Wrap-Up
Watch Video
Intracranial Efficacy of Tucatinib, Palbociclib, and Letrozole in Patients with Hormone Receptor–Positive, HER2-Positive Breast Cancer with Brain Metastases
January 6, 2022
SABCS 2021 Wrap-Up
Watch Video
Safety and Efficacy of a Tucatinib-Trastuzumab-Capecitabine Combination Treatment for Leptomeningeal Metastases in HER2-Positive Breast Cancer
January 6, 2022
SABCS 2021 Wrap-Up
Watch Video
Pelabresib Monotherapy Demonstrates Clinical Activity in a Subset of Patients with Myelofibrosis with Limited Treatment Options and Poor Outcomes
December 18, 2021
Myelofibrosis
Watch Video
Earlier Initiation of Fedratinib May Improve Clinical Profile in Patients with Myelofibrosis Previously Treated with Ruxolitinib
December 18, 2021
Myelofibrosis
Watch Video
AVID200 Improves Platelet Counts in Patients with Myelofibrosis After Discontinuation of Ruxolitinib
December 18, 2021
Myelofibrosis
Watch Video
Fedratinib Improves Overall and Landmark Survival Rates in Patients Diagnosed with Myelofibrosis and Prior Ruxolitinib Treatment
December 18, 2021
Myelofibrosis
Watch Video
Page 1 of 30
1
2
3
4